SEVERE HEMOPHILIA A
Clinical trials for SEVERE HEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new SEVERE HEMOPHILIA A trials appear
Sign up with your email to follow new studies for SEVERE HEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could help control bleeding in severe hemophilia a
Disease control Recruiting nowThis study tests a new medicine called marstacimab in people with severe hemophilia A who have been on another medicine (emicizumab) for at least 6 months. The goal is to see if switching to marstacimab is safe and how it works in the body. About 15 teens and adults aged 12 to 75…
Matched conditions: SEVERE HEMOPHILIA A
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
New hope for hemophilia surgery: can nuwiq safely stop bleeds during operations?
Disease control Recruiting nowThis study tests whether a clotting factor called Nuwiq can safely prevent bleeding during major surgery in people with severe hemophilia A who are already taking another drug (emicizumab) to prevent bleeds. About 28 male patients aged 12 and older will receive Nuwiq around the t…
Matched conditions: SEVERE HEMOPHILIA A
Phase: PHASE4 • Sponsor: Octapharma • Aim: Disease control
Last updated May 15, 2026 11:53 UTC